Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 1, 2010, Pages 31-41

  Crow, J Allen ^a   Herring, Katye L ^a   Xie, Shuqi ^a   Borazjani, Abdolsamad ^a   Potter, Philip M ^b   Ross, Matthew K ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

27 hydroxycholesterol; Arachidonic acid; Carboxylesterase; Cholesteryl ester hydrolase; Fatty acid; Macrophage; Oxysterol; Xenobiotic biotransformation

Indexed keywords

22 HYDROXYCHOLESTEROL; 24,25 EPOXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; ALBUMIN; ARACHIDONIC ACID; BIORESMETHRIN; BOVINE SERUM ALBUMIN; CARBOXYLESTERASE; CHOLESTEROL; FATTY ACID; OXYSTEROL; SATURATED FATTY ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROLYSIS; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; CARBOXYLIC ESTER HYDROLASES; FATTY ACIDS; HUMANS; HYDROLYSIS; HYDROXYCHOLESTEROLS; MACROPHAGES; MICE; MONOCYTES; RECOMBINANT PROTEINS;

EID: 71549137160     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.09.002     Document Type: Article

References (52)

1. Potter P.M., and Wadkins R.M. Carboxylesterases: detoxifying enzymes and targets for drug therapy. Curr. Med. Chem. 13 (2006) 1045-1054
2. Casida J.E. Pest toxicology: the primary mechanisms of pesticide action. Chem. Res. Toxicol. 22 (2009) 609-619
3. Dolinsky V.W., Gilham D., Alam M., Vance D.E., and Lehner R. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell Mol. Life Sci. 61 (2004) 1633-1651
4. Streit T., Borazjani A., Lentz S.E., Wierdl M., Potter P.M., Gwaltney S.R., and Ross M.K. Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibition. Biol. Chem. 389 (2008) 149-162
5. Ghosh S. Cholesteryl ester hydrolase in human monocyte/macrophage: cloning, sequencing and expression of full length cDNA. Physiol. Genomics 2 (2000) 1-8
6. Rothblat G.H., Llera-Moya M.D.L., Favari E., Yancey P.G., and Kellner-Weibel G. Cellular cholesterol flux studies: methodological considerations. Atherosclerosis 163 (2002) 1-8
7. Zhao B., Natarajan R., and Ghosh S. Human liver cholesteryl ester hydrolase: cloning, molecular characterization, and role in cellular cholesterol homeostasis. Physiol. Genomics 23 (2005) 304-310
8. Satoh T., and Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Ann. Rev. Pharmacol. Toxicol. 38 (1998) 257-288
9. Godin S.J., Crow J.A., Scollon E.J., Hughes M.F., DeVito M.J., and Ross M.K. Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate. Drug Metab. Dispos. 35 (2007) 1664-1671
10. -/- mice. J. Clin. Invest. 117 (2007) 2983-2992
11. Crow J.A., Middleton B.L., Borazjani A., Hatfield M.J., Potter P.M., and PM M.K. Ross, Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochim. Biophys. Acta 1781 (2008) 643-654
12. Gill S.R., Chow R., and Brown A.J. Sterol regulators of cholesterol homeostais and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47 (2008) 391-404
13. Janowski B.A., B. A., Willy P.J., Rama Devi T., Falck J.R., and Mangelsdorf D.J. An oxysterol signaling pathway mediated by the nuclear receptor LXRα. Nature 383 (1996) 728-731
14. Lehman J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.-L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140
15. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387
16. Ory D.S. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?. Circ. Res. 95 (2004) 660-670
17. Ouimet M., Wang M.-D., Cadotte N., Ho K., and Marcel Y.L. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1144-1150
18. Desvergne B., and Wahli W. Peroxisome prolififerator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
19. Ghosh S., and Natarajan R. Cloning of the human cholesteryl ester hydrolase promoter: identification of functional peroxisomal proliferator-activated receptor responsive elements. Biochem. Biophys. Res. Comm. 284 (2001) 1065-1070
20. Stewart J.M., and Blakely J.A. Long chain fatty acids inhibit and medium chain fatty acids activate mammalian cardiac hexokinase. Biochim. Biophys. Acta 1484 (2000) 278-286
21. Elabbadi N., Day C.P., Gamouh A., Zyad A., and Yeaman S.J. Relationship between the inhibition of phosphatidic acid phosphohydrolase-1 by oleate and oleoyl-CoA ester and its apparent translocation. Biochimie 87 (2005) 437-443
22. Murthy S.N., Chung P.H., Lin L., and Lomasney J.W. Activation of phospholipase C epsilon by free fatty acids and cross talk with phospholipase D and phospholipase A2. Biochemistry 45 (2006) 10987-10997
23. Tsoutsikos P., Miners J.O., Stapleton A., Thomas A., Sallustio B.C., and Knights K.M. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyl transferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem. Pharmacol. 67 (2004) 191-199
24. Rowland A., Gaganis P., Elliot D.J., Mackenzie P.I., Knights K.M., and Miners J.O. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation. J. Pharmacol. Exp. Ther. 321 (2007) 137-147
25. Rowland A., Elliot D.J., Knights K.M., Mackenzie P.I., and Miners J.O. The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9. Drug Metab. Dispos. 36 (2008) 870-877
26. Brash A.R. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107 (2001) 1339-1345
27. Bencharit S., Edwards C.C., Morton C.L., Howard-Williams E.L., Kuhn P., Potter P.M., and Redinbo M.R. Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1. J. Mol. Biol. 363 (2006) 201-214
28. Tagore R., Thomas H.R., Homan E.A., Munawar A., and Saghatelian A. A global metabolite profiling approach to identify protein-metabolite interactions. J. Am. Chem. Soc. 130 (2008) 14111-14113
29. Wadkins R.M., Hyatt J.L., Wei X., Yoon K.J., Wierdl M., Edwards C.C., Morton C.L., Obenauer J.C., Damodaran K., Beroza P., Danks M.K., and Potter P.M. Identification and characterization of novel benzil (diphenylethane-1,2-dione)analogues as inhibitors of mammalian carboxylesterases. J. Med. Chem. 48 (2005) 2906-2915
30. Crow J.A., Borazjani A., Potter P.M., and Ross M.K. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol. Appl. Pharmacol. 221 (2007) 1-12
31. Morton C.L., and Potter P.M. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression. Application to a rabbit liver carboxylesterase. Mol. Biotechnol. 16 (2000) 193-202
32. Sanghani S.P., Davis W.I., Dumaual N.G., Mahrenholz A., and Bosron W.F. Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. Eur. J. Biochem. 269 (2002) 4387-4398
33. Ross M.K., and Borazjani A. Enzymatic activity of human carboxylesterases. Curr. Protoc. Toxicol. Unit 14 24 (2007) 1-14
34. Morgan E.W., Yan B.D., Greenway D., Petersen D.R., and Parkinson A. Purification and characterization of two rat liver microsomal CEs (hydrolase A and B). Arch. Biochem. Biophys. 315 (1994) 495-512
35. Ross M.K., Borazjani A., Edwards C.C., and Potter P.M. Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem. Pharmacol. 71 (2006) 657-669
36. Wadkins R.M., Hyatt J.L., Yoon K.J., Morton C.L., Lee R.E., Damodaran K., Beroza P., Danks M.K., and Potter P.M. Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity. Mol. Pharmacol. 65 (2004) 1336-1343
37. Webb J.L. Enzyme and metabolic inhibitors. General Principles of Inhibition Vol. 1 (1963), Academic Press Inc., New York
38. Segel I. Biochemical calculations: how to solve mathematical problems in general biochemistry. Second Ed. (1976), John Wiley and Sons, New York.
39. The Human Metabolome Database (HMDB) version 2.0, www.hmdb.ca/metabolites/ HMDB02103, accessed February 6, 2009.
40. Hyatt J.L., Tsurkan L., Wierdl M., Edwards C.C., Danks M.K., and Potter P.M. Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity. Mol. Cancer Ther. 5 (2006) 2281-2288
41. Ross M.K., and Crow J.A. Role of carboxylesterases in xenobiotic and endobiotic metabolism. J. Biochem. Mol. Toxicol. 21 (2007) 187-196
42. Zhao B., Song J., St Clair R., and Ghosh S. Stable over-expression of human macrophage cholesteryl ester hydrolase (CEH) results in enhanced free cholesterol efflux from human THP1-macrophages. Am. J. Physiol. Cell Physiol. 292 (2007) C405-C412
43. Okazaki H., Igarashi M., Nishi M., Tajima M., Sekiya M., Okazaki S., Yahagi N., Ohashi K., Tsukamoto K., Amemiya-Kudo M., Matsuzaka T., Shimano H., Yamada N., Aoki J., Morikawa R., Takanezawa Y., Arai H., Nagai R., Kadowaki T., Osuga J., and Ishibashi S. Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis. Diabetes 55 (2006) 2091-2097
44. Okazaki H., Igarashi M., Nishi M., Sekiya M., Tajima M., Takase S., Takanashi M., Ohta K., Tamura Y., Okazaki S., Yahagi N., Ohashi K., Amemiya-Kudo M., Nakagawa Y., Nagai R., Kadowaki T., Osuga J., and Ishibashi S. Identification of neutral cholesterol ester hydrolase, a key enzyme removing cholesterol from macrophages. J. Biol. Chem. 283 (2008) 33357-33364
45. Schwer H., Langmann T., Daig R., Becker A., Aslanidis C., and Schmitz G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun. 233 (1997) 117-120
46. Wong J., Quinn C.M., and Brown A.J. Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 24 (2008) 2365-2371
47. Honda A., Yamashita K., Hara T., Ikegami T., Miyazaki T., Shrai M., Xu G., Numazawa M., and Matsuzaki Y. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J. Lipid Res. 50 (2009) 350-357
48. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1999) 1-28
49. Kobayashi A., Takanezawa Y., Hirata T., Shimizu Y., Misasa K., Kioka N., Arai H., Ueda K., and Matsuo M. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J. Lipid Res. 47 (2006) 1791-1802
50. Venkateswaran A., Repa J.J., Lobaccaro J.-M.A., Bronson A., Mangelsdorf D.J., and Edwards P. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. J. Biol. Chem. 275 (2000) 14700-14707
51. Pegorier J.-P., Le May C., and Girard J. Control of gene expression by fatty acids. J. Nutr. 134 (2004) 2444S-2449S
52. Liu Y., Patricelli M.P., and Cravatt B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14694-14699